Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial
- 1 April 2016
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 119 (1) , 91-96
Abstract
No abstract availableKeywords
Funding Information
- Mutua Madrileña Foundation (AP116122013)
This publication has 40 references indexed in Scilit:
- Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway?Journal of Magnetic Resonance Imaging, 2012
- Does Local Recurrence of Prostate Cancer After Radiation Therapy Occur at the Site of Primary Tumor? Results of a Longitudinal MRI and MRSI StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Intensity-modulated Radiotherapy With Simultaneous Integrated Boost to Dominant Intraprostatic LesionAmerican Journal of Clinical Oncology, 2012
- ESUR prostate MR guidelines 2012European Radiology, 2012
- 70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09Journal of Clinical Oncology, 2010
- Imaging Localized Prostate Cancer: Current Approaches and New DevelopmentsAmerican Journal of Roentgenology, 2009
- Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI studyRadiation Oncology, 2007
- Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 GyJournal of Clinical Oncology, 2006
- Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imagingInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004